Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Luis Gerardo Rodríguez‐Lobato"'
Autor:
Anna deDaniel, Luis Gerardo Rodríguez‐Lobato, Natalia Tovar, M. Teresa Cibeira, David F. Moreno, Aina Oliver‐Caldés, Ignacio Isola, Ester Lozano, Joan Bladé, Laura Rosiñol, Carlos Fernández de Larrea
Publikováno v:
HemaSphere, Vol 8, Iss 5, Pp n/a-n/a (2024)
Abstract The 2/20/20 International Myeloma Working Group (IMWG) score is the most employed risk score in clinical practice to evaluate the risk of progression from smoldering multiple myeloma (SMM) to symptomatic multiple myeloma. However, it faces a
Externí odkaz:
https://doaj.org/article/1de8802a875642aa8d1b51cf74359b01
Autor:
Raquel Jiménez-Segura, Laura Rosiñol, Ma Teresa Cibeira, Carlos Fernández de Larrea, Natalia Tovar, Luis Gerardo Rodríguez-Lobato, Esther Bladé, David F. Moreno, Aina Oliver-Caldés, Joan Bladé
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-8 (2022)
Abstract From January 1970 to December 2018, 1304 patients were diagnosed with multiple myeloma (MM) at our institution and 256 (19.6%) had plasmacytomas (Ps) (paraskeletal –PPs- 17.6%, extramedullary –EMPs-1.9%). Patients with Ps had lower serum
Externí odkaz:
https://doaj.org/article/5e019032e0d549be9f149145a0b9acc3
Autor:
Anthony M. Battram, Aina Oliver-Caldés, Maria Suárez-Lledó, Miquel Lozano, Miquel Bosch i Crespo, Núria Martínez-Cibrián, Joan Cid, David F. Moreno, Luis Gerardo Rodríguez-Lobato, Alvaro Urbano-Ispizua, Carlos Fernández de Larrea
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 26, Iss , Pp 207-223 (2022)
Autologous cell immunotherapy using B cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR)-T cells is an effective novel treatment for multiple myeloma (MM). This therapy has only been used for relapsed and refractory patients, at
Externí odkaz:
https://doaj.org/article/85ce7bb7085742eaa47debfe86d2dbc9
Autor:
Sonia Ruiz-Boy, Alexandra Pedraza, Marta Prat, Maria Queralt Salas, Esther Carcelero, Gisela Riu-Viladoms, María Suárez-Lledó, Inés Monge-Escartín, Luis Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, Montserrat Rovira, Carmen Martínez, Cristina Gallego, Álvaro Urbano-Ispizua, Joan Sánchez, María Ángeles Marcos, Francesc Fernández-Avilés
Publikováno v:
Pharmaceuticals, Vol 16, Iss 12, p 1741 (2023)
Cytomegalovirus (CMV) infection is a relevant cause of morbimortality in patients receiving allogeneic stem cell transplantation (allo-HCT). Foscarnet (FCN) is an effective drug against CMV administered intravenously and usually on an inpatient basis
Externí odkaz:
https://doaj.org/article/7f1d8a9fa215409198a98d3f252d56b2
Autor:
Aina Oliver-Caldes, Juan Carlos Soler-Perromat, Ester Lozano, David Moreno, Alex Bataller, Pablo Mozas, Marta Garrote, Xavier Setoain, Juan Ignacio Aróstegui, Jordi Yagüe, Natalia Tovar, Raquel Jiménez, Luis Gerardo Rodríguez-Lobato, M. Teresa Cibeira, Laura Rosiñol, Joan Bladé, Manel Juan, Carlos Fernández de Larrea
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionMultiple myeloma (MM) is considered an incurable hematological neoplasm. For transplant-eligible patients, initial treatment includes an induction phase followed by an autologous stem cell transplantation (ASCT). Despite the introduction
Externí odkaz:
https://doaj.org/article/e5fabab14d0d45a2ac2c95f79c8116fd
Autor:
Ignacio Isola, Fara Brasó-Maristany, David F. Moreno, Mari-Pau Mena, Aina Oliver-Calders, Laia Paré, Luis Gerardo Rodríguez-Lobato, Beatriz Martin-Antonio, María Teresa Cibeira, Joan Bladé, Laura Rosiñol, Aleix Prat, Ester Lozano, Carlos Fernández de Larrea
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundWe previously reported algorithms based on clinical parameters and plasma cell characteristics to identify patients with smoldering multiple myeloma (SMM) with higher risk of progressing who could benefit from early treatment. In this work,
Externí odkaz:
https://doaj.org/article/b9061fb81fbb4274961401c2b3964701
Autor:
Luis Gerardo Rodríguez-Lobato, Maya Ganzetti, Carlos Fernández de Larrea, Michael Hudecek, Hermann Einsele, Sophia Danhof
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Despite recent therapeutic advances, the prognosis of multiple myeloma (MM) patients remains poor. Thus, new strategies to improve outcomes are imperative. Chimeric antigen receptor (CAR) T-cell therapy has changed the treatment landscape of B-cell m
Externí odkaz:
https://doaj.org/article/f873d6c5f8cc4da4902803586b2ce2ca
Autor:
Mireia Uribe-Herranz, Nela Klein-González, Luis Gerardo Rodríguez-Lobato, Manel Juan, Carlos Fernández de Larrea
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 3, p 1026 (2021)
Hematological malignancies, including multiple myeloma, lymphoma, and leukemia, are a heterogeneous group of neoplasms that affect the blood, bone marrow, and lymph nodes. They originate from uncontrolled growth of hematopoietic and lymphoid cells fr
Externí odkaz:
https://doaj.org/article/afb2e0126ef8447580697bd8498b740f
Autor:
Amanda Isabel Pérez-Valencia, Enric Cascos, Sara Carbonell-Ordeig, Paola Charry, Marta Gómez-Hernando, Luis Gerardo Rodríguez-Lobato, María Suárez-Lledó, Nuria Martínez-Cibrian, María Gabriela Antelo, María Teresa Solano, Jordi Arcarons, Meritxell Nomdedeu, Joan Cid, Miquel Lozano, Maribel Díaz-Ricart, Laura Rosiñol, Jordi Esteve, Álvaro Urbano-Ispizua, Enric Carreras, Carmen Martínez, Francesc Fernández-Avilés, Montserrat Rovira, María Queralt Salas
Publikováno v:
Blood Advances. 7:2018-2031
This study investigates early cardiac events (ECE) occurring during the first 180 days after allo-HCT in 416 adults receiving PTCY (n=258) and non-receiving PTCY (n=158). Total body irradiation (TBI) was given to 133 (31.9%) patients, in 111 (83.4%)
Autor:
David F. Moreno, Mónica López‐Guerra, Sara Paz, Aina Oliver‐Caldés, Mari‐Pau Mena, Juan G. Correa, Anthony M. Battram, Miguel Osuna, Alfredo Rivas‐Delgado, Luis Gerardo Rodríguez‐Lobato, Oriol Cardús, Natalia Tovar, María Teresa Cibeira, Raquel Jiménez‐Segura, Joan Bladé, Laura Rosiñol, Dolors Colomer, Carlos Fernández de Larrea
Publikováno v:
British Journal of Haematology. 200:187-196